Jennifer Lynn Minai-Azary
Chief Financial Officer · Context Therapeutics Inc.
Individual
- 2026
- Feb 23, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jennifer Lynn Minai-Azary's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- Steven Leonard Chapman - $89.87M in NTRA purchases and sales in the last 12 months
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jennifer Lynn Minai-Azary?
Jennifer Lynn Minai-Azary is a corporate insider, tracked as Chief Financial Officer of Context Therapeutics Inc. (CNTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jennifer Lynn Minai-Azary last file a Form 4?
The only primary Form 4 on record is dated 23 February 2026.